Evidence map›Paper›PMID 31676976›Full record

Observational studyLung2019

Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease.

Lars Hagmeyer, Simon Herkenrath, Norbert Anduleit, Marcel Treml, Winfried Randerath

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Lung, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Lars HagmeyerHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany. lars.hagmeyer@klinik-bethanien.de.ORCID 0000-0003-4285-1244
Simon HerkenrathHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.
Norbert AnduleitHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.
Marcel TremlHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.
Winfried RanderathHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is unclear whether there are cardiopulmonary exercise testing (CPET) parameters which may indicate poor prognosis in the early course of fibrosing interstitial lung disease. 27 untreated consecutive subjects (13 idiopathic non-specific interstitial pneumonia (iNSIP), 14 idiopathic pulmonary fibrosis (IPF); 19 male; age 69 ± 10 years) were enrolled in this observational pilot study. Subjects underwent routine pulmonary function testing and CPET. Statistically, the t test and the Mann-Whitney-U test were applied in the presence of normal and non-normal distribution (according to Shapiro-Wilk), respectively. Analyzing the whole cohort, only mild functional impairments were determined. Comparison of iNSIP and IPF groups detected significant differences for the CPET parameters V'O

Indexed as

Diagnosis, DifferentialAgedCarbon DioxideExercise TestFemaleHumansIdiopathic Interstitial PneumoniasIdiopathic Pulmonary FibrosisMaleMiddle AgedOxygen ConsumptionPilot ProjectsPlethysmography, Whole BodyProspective StudiesPulmonary Diffusing CapacityRespiratory Function TestsCarbon DioxideInterstitial lung diseaseLung fibrosisPrognosisPulmonary function test

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.